The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor MR, and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
本发明涉及11-β羟基类
固醇脱氢酶类型1的
抑制剂,矿物
皮质激素受体MR的
拮抗剂以及其药物组成物。本发明的化合物可用于治疗与11-β羟基类
固醇脱氢酶类型1的表达或活性以及与
醛固酮过度相关的各种疾病。